Search

everythinglearnresearchcommunity

for

Search:↓

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Taking 5-ARI before prostate laser surgery may lead to more blood changes, longer surgery, and more urinary issues.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

PRP injections are safe but don't significantly improve Peyronie's Disease.

Presurgical models can effectively and affordably screen cancer prevention agents.

Osaterone acetate reduces prostate size and enzyme levels in dogs with benign prostatic hyperplasia.

Finasteride may effectively reduce Tourette's syndrome symptoms and improve life quality.

Pneumatic Skin Flattening (PSF) significantly reduces pain during laser and IPL hair removal.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Narrowband Ultraviolet B treatment can significantly reduce anxiety in psoriasis patients, but it doesn't significantly affect depression.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

The U.K. created the CPSA to set safety standards for non-surgical cosmetic treatments and improve patient protection.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Finasteride may help reduce impulsivity caused by pramipexole.

Finasteride may help improve certain brain function issues linked to dopamine.

5-alpha reductase inhibitors help treat prostate issues in aging men, but their role in cancer prevention is debated.

Chemoprevention, using drugs like finasteride and dutasteride, can help prevent prostate cancer.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

Finasteride effectively reduces DHT and E2 levels, helping with prostate enlargement.

The correction states that the label change for Finasteride was in 2012, leading to more reports of side effects from non-healthcare people.

Reducing out-of-pocket costs increased colorectal cancer screenings.